U.S. markets open in 8 hours 30 minutes
  • S&P Futures

    4,119.50
    -7.00 (-0.17%)
     
  • Dow Futures

    33,665.00
    -38.00 (-0.11%)
     
  • Nasdaq Futures

    13,741.00
    -53.25 (-0.39%)
     
  • Russell 2000 Futures

    2,181.50
    -2.50 (-0.11%)
     
  • Crude Oil

    62.61
    +0.17 (+0.27%)
     
  • Gold

    1,781.50
    +3.10 (+0.17%)
     
  • Silver

    25.90
    +0.06 (+0.21%)
     
  • EUR/USD

    1.2032
    -0.0009 (-0.07%)
     
  • 10-Yr Bond

    1.5620
    0.0000 (0.00%)
     
  • Vix

    18.68
    +1.39 (+8.04%)
     
  • GBP/USD

    1.3923
    -0.0014 (-0.10%)
     
  • USD/JPY

    108.0550
    -0.0150 (-0.01%)
     
  • BTC-USD

    55,505.73
    +702.50 (+1.28%)
     
  • CMC Crypto 200

    1,274.54
    +40.12 (+3.25%)
     
  • FTSE 100

    6,859.87
    -140.21 (-2.00%)
     
  • Nikkei 225

    28,509.16
    -591.22 (-2.03%)
     

IRTC Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies iRhythm Technologies, Inc. Shareholders of Class Action and Encourages Shareholders to Contact the Firm

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against iRhythm Technologies, Inc. ("iRhythm" or "the Company") (NASDAQ: IRTC) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired iRhythm securities between August 4, 2020 and January 28, 2021, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/irtc.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, and failed to disclose to investors that: (1) iRhythm’s business would suffer as a result of the U.S. Centers for Medicare and Medicaid Services’ ("CMS") rulemaking; (2) reimbursement rates would in fact plummet; (3) a lack of national pricing in the CMS rule and fee schedule would cause uncertainty and weakness in the Company’s business; and (4) as a result of the foregoing, the iRhythm Defendants’ public statements were materially false and misleading at all relevant times.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/irtc or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in iRhythm you have until April 2, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210224005951/en/

Contacts

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com